These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6853137)

  • 21. [Acetylator state in diabetes mellitus and ischemic heart disease].
    Rohla M; Várnai Z; Balázsi I
    Orv Hetil; 1983 Jul; 124(31):1865-6. PubMed ID: 6634136
    [No Abstract]   [Full Text] [Related]  

  • 22. Acetylator phenotyping: the effect of ethanol on the dapsone test.
    Hutchings A; Monie RD; Spragg B; Routledge PA
    Br J Clin Pharmacol; 1984 Jul; 18(1):98-100. PubMed ID: 6743494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inactivation of drugs by acetylation].
    Walstad RA
    Tidsskr Nor Laegeforen; 1975 Jan; 95(2):100-3. PubMed ID: 1114495
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.
    Ahmad RA; Rogers HJ; Vandenburg M; Wright P
    Br J Clin Pharmacol; 1981 Jul; 12(1):83-6. PubMed ID: 7248142
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.
    Hein DW; Doll MA; Ferguson RJ
    Proc West Pharmacol Soc; 1995; 38():59-62. PubMed ID: 7480023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methemoglobinemia and hemolytic anemia induced by Disulon].
    De Prost Y; Hornac P; Galacteros F; Penev M; Revuz J; Touraine R
    Ann Dermatol Venereol; 1982; 109(12):1025-9. PubMed ID: 7171199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between high incidence of adverse dapsone reactions and slow acetylate phenotype or low plasma/lymphocyte glutathione level.
    Guo R; Thormann W; Lauterberg B
    Chin Med J (Engl); 1996 Dec; 109(12):933-6. PubMed ID: 9275325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary excretion of hydroxyproline in patients with rheumatoid arthritis].
    Iwańska J; Okrzeja Z; Kruze D
    Reumatologia; 1970; 8(3):221-8. PubMed ID: 5469428
    [No Abstract]   [Full Text] [Related]  

  • 32. [N-acetyltransferase activity in persons with sclerotic vascular lesions].
    Seleznev NG; Shval'b PG; Kovalev IE
    Klin Med (Mosk); 1985 Apr; 63(4):21-4. PubMed ID: 4032998
    [No Abstract]   [Full Text] [Related]  

  • 33. Inheritance of acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acetylation phenotype in psoriasis].
    Olszewska Z; Orłowska-Westwood B; Orszulak D; Jabłkowska-Gajdzińska J; Skretkowicz J
    Przegl Dermatol; 1980; 67(1):19-22. PubMed ID: 7375649
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis.
    Baggott JE; Bridges SL; Morgan SL
    Arthritis Rheum; 2005 Jan; 52(1):356-8. PubMed ID: 15641087
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological aspects of the pathogenesis of periodontosis].
    Piruzian LA; Kharchenko SV; Gladkikh SP; Radchenko IV; Brezhneva EG
    Izv Akad Nauk SSSR Biol; 1983; (2):251-9. PubMed ID: 6853825
    [No Abstract]   [Full Text] [Related]  

  • 38. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.
    Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T
    Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
    Bluhm RE; Adedoyin A; McCarver DG; Branch RA
    Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.